Stock Fundamentals

Company Information

Company Name
Harvard Bioscience Inc
Sector
Healthcare
Industry
Medical Instruments & Supplies
Exchange
NASDAQ
ISIN: US4169061052
CIK: 0001123494
CUSIP: 416906105
Currency: USD
Full Time Employees: 316
Phone: 508 893 8999
Fiscal Year End: December
IPO Date: Dec 07, 2000
Description:

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through websites and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic laboratories. It primarily sells its products under the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS, Warner, DSI, Panlab, Hugo Sachs, and Buxco brands. Harvard Bioscience, Inc. was founded in 1901 and is based in Holliston, Massachusetts.

Address:

84 October Hill Road, Holliston, MA, United States, 01746

Directors & Officers

Name Title Year Born
Mr. John Duke President, CEO & Director 1971
Mr. Mark T. Frost CFO, Treasurer, Principal Financial Officer & Principal Accounting Officer 1963
Ms. Lori Packer Vice President of Global People Operations NA
Mr. David Panzarella Senior Vice President of Commercial NA
Kathryn Flynn Corporate Controller NA
David Sirois Director of Corporate Accounting & SEC Reporting NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Mar 17, 2026 Stephen J Denelsky N/A Purchase 10.00K $4.87 $48.70K
Mar 17, 2026 William Snider N/A Purchase 8.48K $4.85 $41.10K
Mar 16, 2026 John D Duke N/A Purchase 5.00K $5.01 $25.05K
Mar 16, 2026 William Snider N/A Purchase 12.53K $4.99 $62.50K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Vanguard Group Inc 1.92M Dec 31, 2025 4.26% $0.00 3.86%
Two Sigma Advisers, LLC 878.56K Dec 31, 2025 1.95% $0.00 261.31%
Weber Capital Management LLC 320.04K Mar 31, 2026 7.10% $1.56 -90.00%
Acadian Asset Management LLC 179.61K Mar 31, 2026 3.98% $0.00 0.00%
Vanguard Capital Management, LLC 163.31K Mar 31, 2026 3.62% $0.00 0.00%
Corsair Capital Management LLC 124.81K Mar 31, 2026 2.77% $0.09 -88.74%
Meros Investment Management, LP 118.52K Mar 31, 2026 2.63% $0.25 -90.27%
NANO CAP NEW MILLENNIUM GROWTH FUND L P 117.50K Mar 31, 2026 2.61% $0.54 -80.42%
Two Sigma Investments LLC 114.12K Mar 31, 2026 2.53% $0.00 -88.73%
Renaissance Technologies Corp 101.43K Mar 31, 2026 2.25% $0.00 -90.07%
BlackRock Inc 62.23K Mar 31, 2026 1.38% $0.00 -90.00%
Geode Capital Management, LLC 59.51K Mar 31, 2026 1.32% $0.00 -87.09%
Millennium Management LLC 46.33K Mar 31, 2026 1.03% $0.00 -91.52%
Vanguard Fiduciary Trust Co 27.73K Mar 31, 2026 0.61% $0.00 0.00%
Williams & Novak LLC 27.05K Mar 31, 2026 0.60% $0.10 -92.24%
Essex Investment Management Company, LLC 27.02K Mar 31, 2026 0.60% $0.02 -85.37%
Group One Trading, LP 25.51K Dec 31, 2025 0.06% $0.00 1,307.23%
Jane Street Group LLC 23.83K Mar 31, 2026 0.53% $0.00 -94.26%
RBF LLC 16.00K Mar 31, 2026 0.35% $0.00 -95.00%
State Street Corp 14.93K Mar 31, 2026 0.33% $0.00 -90.00%

Shares Statistics

Shares Outstanding: 4.51M
Shares Float: 3.50M
% Insiders: 948.30%
% Institutions: 4,145.70%
Short % Float: 1.60%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 123.47K 2.74% ▲ 0.00% Apr 30, 2026
2 Acuitas US Microcap Strategy 102.35K 2.27% ▼ 89.99% Mar 31, 2026
3 Extended Equity Market Fund B 77.39K 0.17% ▲ 0.00% Dec 31, 2025
4 Extended Equity Market Fund E 77.39K 0.17% ▲ 0.00% Dec 31, 2025
5 Essex Inv Mgt Micro Cap Growth 43.47K 0.10% ▲ 0.00% Dec 31, 2025
6 Vanguard Institutional Extnd Mkt Idx Tr 42.04K 0.93% ▲ 5.52% Apr 30, 2026
7 Fidelity Extended Market Index 33.19K 0.74% ▼ 0.36% Apr 30, 2026
8 Acuitas US Microcap Institutional 8.78K 0.19% ▼ 89.99% Mar 31, 2026
9 Blackrock Extended Mkt Fund CF 7.74K 0.17% ▲ 0.00% Apr 30, 2026
10 Spartan Extended Market Index Pool F 7.14K 0.16% ▲ 1.72% Apr 30, 2026

Valuation Metrics

Enterprise Value: $64.72M
Trailing P/E: 0.00
Forward P/E: 15.06

Financial Highlights

Market Cap: $27.69M
EBITDA: $7.82M
PEG Ratio: $1.31
Book Value: $2.23
Earnings/Share: $-2.15
Profit Margin: -11.44%
Operating Margin: -4.52%
ROA (TTM): 1.73%
ROE (TTM): -78.65%
Revenue (TTM): $85.53M
Revenue/Share (TTM): $19.20
Earnings Growth (YOY): -80.30%
Revenue Growth (YOY): -4.70%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 2.20x 2.72x 0.83x -0.13x -0.80x
2024-12-31 0.82x 0.60x 0.50x -1.94x -25.86x
2023-12-31 1.85x 0.52x 0.47x 0.53x 4.73x
2022-12-31 2.20x 0.68x 0.50x -2.72x 51.86x
2021-12-31 2.43x 0.61x 0.49x 1.34x 5.59x
2020-12-31 2.46x 0.65x 0.51x 0.05x 9.69x
2019-12-31 2.12x 0.69x 0.50x 0.07x 7.36x
2018-12-31 2.54x 0.74x 0.51x 0.18x 11.34x
2017-12-31 3.39x 0.15x 0.26x -0.14x -116.32x
2016-12-31 3.11x 0.19x 0.33x -4.67x 7.64x
2015-12-31 2.60x 0.24x 0.35x -2.01x 10.90x
2014-12-31 2.81x 0.22x 0.30x 6.68x 2.31x
2013-12-31 3.78x 0.26x 0.30x 1.61x 3.23x
2012-12-31 5.96x 0.25x 0.22x 5.42x 2.22x
2011-12-31 6.02x 0.34x 0.25x 8.08x 2.73x
2010-12-31 4.51x 0.20x 0.28x 15.09x 1.31x
2009-12-31 3.70x 0.18x 0.30x 29.08x 1.01x
2008-12-31 3.88x 0.02x 0.18x 21.80x 0.13x
2007-12-31 3.32x 0.10x 0.25x 26.12x 0.81x
2006-12-31 3.63x 0.08x 0.23x 20.26x 0.69x
2005-12-31 4.26x 0.12x 0.26x 8.64x 0.66x
2004-12-31 3.82x 0.16x 0.25x 5.52x 1.12x
2003-12-31 3.58x 0.13x 0.23x 23.42x 1.02x
2002-12-31 2.92x 0.01x 0.18x 15.75x 0.16x
2001-12-31 3.68x 0.07x 0.19x -678.49x 1.21x
2000-12-31 7.37x 0.00x 0.11x -11.27x 0.00x
1999-12-31 1.50x 0.38x 0.61x N/A 1.25x
1998-12-31 N/A 0.00x 0.91x N/A 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about HBIO.US!